In this section
CCG Approval Status:
The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of RISANKIZUMAB (Skyrizi®▼), by specialists only, for previously treated moderately to severely active Crohn's disease in accordance with NICE TA888.
NHS Cheshire and Merseyside APPROVED
